Over 44 million people worldwide currently suffer from dementia, and that number is projected to triple in the next 30 years! As the prevalence of Alzheimer’s disease continues to climb, many are sadly watching their loved ones succumb to the disease’s mind vanishing effects.
Alzheimer’s has devastating effects on the daily lives of those afflicted with the disease. As a result, a heavy care burden is often placed on their loved ones – as well as the medical industry. In the United States, Alzheimer’s disease has now surpassed 250 billion dollars a year in annual health care related costs – most of which is paid for by tax dollars through Medicare and Medicaid. In fact, at it’s current growth rate, Alzheimer’s disease related costs alone have the potential to bankrupt Medicare in the next 5 to 10 years!
To date, all attempts to find a cure for Alzheimer’s disease by the pharmaceutical industry have failed miserably. In fact, many clinic trials demonstrated that patients on the trialed medication declined faster than patients who took placebo medication.
Thanks to the pioneering research by leading innovators in Alzheimer’s disease, including Dr. Dale Bredesen, Dr. Rudolph Tanzi, Dr. David Perlmutter, and Dr. Aristo Vojdani, and our Regenera Medical founder, Dr. Elroy Vojdani, we are beginning to understand the complex mechanism of this debilitating disease. Through this distinguished team’s groundbreaking efforts, progression of Alzheimer’s can now be stopped and/or reversed in some patients. The first two parts of this research has been accepted for publication in the Journal of Alzheimer’s disease and the International Journal of Alzheimer’s disease.
Western medicine’s previous notion that Alzheimer’s disease is entirely genetic, and that those dealt a poor hand are doomed, is simply not the case. While genetic predisposition does play a role in the disease, the team’s studies revealed that genetics is a minority contributor. The most significant finding from this group of notable science-based thought leaders, is that the largest contributing factor to developing Alzheimer’s disease is one’s environment.
The following are the top 7 key contributors to the potential development of Alzheimer’s:
• Prior infections
• Gut disorders such as intestinal permeability and/or Irritable Bowel Syndrome (IBS)
• Food immune reactivity
• Hormone imbalances
• Toxin exposure to things like heavy metals or mold
History of physical brain trauma
These scientific findings are truly groundbreaking.Up until now, medical professionals were taught to believe that Alzheimer’s disease was a result of one single dysfunctional process (genetics causing plaque build up on the brain). As a result of this team’s pioneering work, we now have scientific proof that Alzheimer’s is the result of several years of individual exposures. With these findings, medical professionals should now turn their attention to identifying the specific factors that play a role in each person’s disease. Once the contributing factors have been isolated, a customized treatment plan can be created to address the root cause of the condition. Without addressing these underlying issues, any attempts at treating the disease will be futile.
As part of a recent Alzheimer’s research project by Dr. Datis Kharrazian, Dr. Elroy Vojdani and his father, Dr. Aristo Vojdani (known as the “The Father of Functional Immunology”), the team examined the exposure to infectious agents, toxic chemicals, and foods in relation to the development of Amyloid plaque – the cause of the symptoms of Alzheimer’s disease. The team concretely demonstrated how environmental exposure can play a role in the development and accumulation of Beta Amyloid plaque formation in the brain – the hallmark sign of Alzheimer’s disease. Now that these various causes have been clearly identified, they can be specifically identified through the use of a simple blood screening – far in advance of the actual disease and as much as 30 years before the first signs of Alzheimer’s appear!
As a result of these findings, the future of treating this disease is now going to center around early detection and preventative focused treatment.
You no longer have to wait until you are in your 70’s, or when you start showing signs of dementia, to identify if you are at risk for developing Alzheimer’s disease. By testing for the disease in your 40’s or 50’s, and commencing treatment (if your test show positive), you can significantly decrease the escalation of the debilitating stages of the disease. The Regenera Medical team encourages you to get yourself screened at a time in your life when treatment is simpler and more effective – not only for yourself, but also for the sake of your loved ones who will not have to endure the emotional and often financial hardships of having a parent or spouse experience the eviscerating effects of Alzheimer’s disease.